BioXcel Therapeutics, Inc. (BTAI) Financials
BTAI Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 34.0 million | 139.6 million |
| Dec. 31, 2025 | 44.9 million | 140.4 million |
| Sept. 30, 2025 | 44.8 million | 133.7 million |
| June 30, 2025 | 25.8 million | 133.5 million |
BTAI Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | -11.8 million | 435000 |
| Dec. 31, 2025 | -14.2 million | 450000 |
| Sept. 30, 2025 | -18.8 million | 581000 |
| June 30, 2025 | -12.6 million | 1.6 million |
BTAI Net Income
No data available :(
BTAI Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 17.2 million | 77.9 million | - |
| Dec. 31, 2025 | 28.4 million | 84.7 million | 65000 |
| Sept. 30, 2025 | 37.3 million | 92.3 million | 161000 |
| June 30, 2025 | 17.4 million | 97.5 million | 256000 |
BTAI Shares Outstanding
BTAI Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | - | 3.0 million | 7.2 million | - |
| Dec. 31, 2025 | - | 6.7 million | 3.8 million | 85000 |
| Sept. 30, 2025 | - | 8.7 million | 5.4 million | 115000 |
| June 30, 2025 | - | 10.3 million | 5.6 million | 38000 |
BTAI Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | 206000 | 341000 |
| Dec. 31, 2025 | 256000 | 32000 |
| Sept. 30, 2025 | 98000 | 11000 |
| June 30, 2025 | 120000 | 107000 |
BTAI
Price: $1.16
52 week price:
Earnings Per Share: -4.77 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 510800
Market Capitalization: 29.5 million